文献速递妇产影像腹部泌尿生殖CTMR

妇科恶性肿瘤治疗后的盆腔影像评估

Imaging the post-treatment pelvis with gynecologic cancers.
PubMed 文献 · Abdom Radiol (NY) · 2024-02-10

本文综述妇科恶性肿瘤(卵巢癌、宫颈癌、子宫内膜癌)治疗后盆腔并发症的影像表现,涉及手术、化疗和放疗后的血肿、脓肿、包涵囊肿、血清肿、肿瘤血栓、肛门直肠阴道瘘和纱布瘤等,按早期与晚期并发症区分,CT和MRI是主要评估手段,MRI更常用于准确评估肿瘤大小和局部侵犯。

要点

  • 妇科肿瘤治疗后并发症可累及泌尿生殖、胃肠、神经和骨骼肌肉系统,CT和MRI是主要评估手段。
  • 需区分早期与晚期并发症,影像表现是鉴别关键。
  • MRI常用于更准确评估肿瘤大小和检测局部侵犯。

核心结论

  • 本综述按早期与晚期并发症分类,呈现妇科恶性肿瘤治疗后最常见并发症的影像学表现,以帮助鉴别诊断。

研究设计与样本

  • 综述,检索范围与纳入文献数原文未报告。

关键影像表现/征象

  • 治疗后可能出现的并发症包括血肿、脓肿、包涵囊肿、血清肿、肿瘤血栓、肛门直肠阴道瘘和纱布瘤。
  • 并发症可影响泌尿生殖系统、胃肠道、神经系统和骨骼肌肉系统。

临床应用与阅片要点

  • CT和MRI可用于初始评估和检测治疗后并发症。
  • CT主要用于分期,MRI常用于更准确评估肿瘤大小和检测局部侵犯。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Gynecological malignancies, such as ovarian cancers, cervical cancers, and endometrial cancers, have a significant global impact. Women with gynecologic malignancies may receive a single or a combination of treatments, including surgery, chemotherapy, and radiation-based therapies. Radiologists utilize various diagnostic imaging modalities to provide the surgeon with relevant information about the diagnosis, prognosis, optimal surgical strategy, and prospective post-treatment imaging. Computerized Tomography (CT) and magnetic resonance imaging (MRI) may be used initially to evaluate and detect post-treatment complications. Although CT is primarily used for staging, MRI is commonly used for a more accurate evaluation of a tumor's size and detection of local invasion. Complications such as hematoma, abscess, inclusion cyst, seroma, tumor thrombosis, anorectovaginal fistula, and gossypiboma may occur after the three primary treatments, and systems such as the genitourinary, gastrointestinal, neurological, and musculoskeletal may be affected. In order to distinguish between early-onset and late-onset complications following gynecological treatment, radiological findings of the most common post-treatment complications will be presented in this review.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Moradi B, Hejazian SS, Tahamtan M, et al. Imaging the post-treatment pelvis with gynecologic cancers. Abdom Radiol (NY). 2024. PMID: 38340181. doi:10.1007/s00261-023-04163-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。